Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02119663
Title A Study of Ruxolitinib in Pancreatic Cancer Patients
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA | SWE | NLD | ISR | IRL | FRA | DNK | CHE | AUT


No variant requirements are available.